Medstone's STS-T
This article was originally published in The Gray Sheet
Executive Summary
Transportable lithotripter PMA supplement has been approved by FDA, the firm reports Sept. 18. A smaller version of Medstone's flagship STS lithotripter, the STS-T "will address the market's movement to the less expensive, more transportable lithotripsy systems," according to the company